The Massachusetts Biotechnology Council (MassBio) announced Sept. 16 that it has agreed to an expanded partnership with Veolia North America, Boston, for its savings and rewards program, MassBio Edge. Under the agreement, Veolia will serve as MassBio’s preferred partner for all streams of waste management.
MassBio is a not-for-profit organization that represents and provides services and support for the Massachusetts life sciences industry. Representing more than 1,300 member companies, MassBio works to advance policy and promote education while providing member programs and events, industry information, and services
Specifically, MassBio says Veolia will be a resource for transportation, disposal, training and regulatory guidance related to all types of hazardous, non-hazardous, regulated medical waste and low-level radioactive materials, and will offer comprehensive recycling and waste to energy programs.
“Our members are developing the next generation of breakthrough therapies, and as the pace of innovation accelerates, improving patient outcomes should remain at the crux of their work, not concerns over medical and pharmaceutical waste disposal,” Jason Cordeiro, vice president of Edge operations at MassBio, says. “With this expanded partnership, we are excited to provide our members with consolidated waste management services so they can have the peace of mind to focus on what they do best.”
As a resource for all MassBio members, Veolia provides a range of services for life sciences, biotechnology, universities, hospitals, industrial and municipal customers needing to dispose of their waste out of its more than 45 sales, services, treatment and disposal facilities in the United States.
“The proper management and recycling of waste is critical to the future success of the life sciences, and we’re looking forward to working with MassBio’s vast membership to provide dependable waste management services, reduce their environmental footprint, provide regulatory guidance and support the advancement of the industry,” Bob Cappadona, executive vice president and COO of Veolia North America, says. “We’re thrilled to continue our successful partnership with MassBio and facilitate additional savings for the most innovative companies so they can further invest in research and development.”